mCommunicable Disease Prevention and Control, Ministry of Health, Kampala, Uganda nNon-Communicable Diseases Control Programme, Ministry of Health, Kampala, Uganda ...

Patient dosing has commenced in first-of-its-kind Phase 3 head-to-head CAR T-cell 2L randomized controlled clinical trial (PiNACLE-H2H) in patients with large B-cell lymphoma, and the 3L+ pivotal ...

Announced data from cohort 4 of soquelitinib atopic dermatitis Phase 1 trial demonstrating positive safety and efficacy results, including in patients who have received prior systemic therapy ...

MFDS IND approval enables a multicenter, randomized, double-blind, vehicle-controlled phase 2 study in ~150 DED patients, randomized 1:1:1 to two dosing arms versus control over 12 weeks. Prior phase ...

Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced ...

Digitally delivered behavior-change prompts plus short videos can boost GLP-1 users’ expectations to adopt healthy lifestyle behaviors.

US-based biopharmaceutical company Spinogenix has concluded the enrolment of patients in its Phase II clinical trial of tazbentetol (previously known as SPG302), a synaptic regenerative treatment for ...

Severe acute pancreatitis is frequently complicated by hospital-acquired infections that worsen outcomes and prolong intensive care stays. New evidence suggests that modulating the microbiome may ...

Hypertonic saline and mannitol show similar effects on mortality and intracranial pressure control in children with TBI.

Among patients with rheumatoid arthritis-associated interstitial lung disease, there was no significant difference in the ...

Risk-bearing provider organizations rely on physicians to achieve cost savings. The literature on physician-mediated interventions to reduce costs is scant and provides little guidance on effective ...

The prescription drug leucovorin is getting a label update, though it’s not what that the US Food and Drug Administration ...